当前位置: 首页 >> 检索结果
共有 87651 条符合本次的查询结果, 用时 6.2937923 秒

1241. Oral Hairy Leukoplakia. Reply.

作者: Meropi Karakioulaki.;Franziska Schauer.
来源: N Engl J Med. 2025年392卷21期2182页

1242. Oral Hairy Leukoplakia.

作者: Alessandro Villa.;Michele Lodolo.;Sook Bin Woo.
来源: N Engl J Med. 2025年392卷21期2181-2182页

1243. Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia. Reply.

作者: Jennifer R Brown.;Kara Miller.;Veerendra Munugalavadla.
来源: N Engl J Med. 2025年392卷21期2181页

1244. Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.

作者: Mohamad Mohty.;Mohamed A Kharfan-Dabaja.
来源: N Engl J Med. 2025年392卷21期2180-2181页

1245. TAVR for Asymptomatic Severe Aortic Stenosis. Reply.

作者: Stefan Blankenberg.
来源: N Engl J Med. 2025年392卷21期2179-2180页

1246. TAVR for Asymptomatic Severe Aortic Stenosis. Reply.

作者: Philippe Généreux.;Allan Schwartz.;Martin B Leon.
来源: N Engl J Med. 2025年392卷21期2178-2179页

1247. TAVR for Asymptomatic Severe Aortic Stenosis.

作者: Marco Barbanti.;Giuliano Costa.
来源: N Engl J Med. 2025年392卷21期2178页

1248. TAVR for Asymptomatic Severe Aortic Stenosis.

作者: Johann Auer.;Hendrik J Ankersmit.;Lisa Auer.
来源: N Engl J Med. 2025年392卷21期2177-2178页

1249. TAVR for Asymptomatic Severe Aortic Stenosis.

作者: Stefan Toggweiler.;Lucca Loretz.;Christoph Henzen.
来源: N Engl J Med. 2025年392卷21期2177页

1250. TAVR for Asymptomatic Severe Aortic Stenosis.

作者: Benjamin U Hoffman.;Ori Ben-Yehuda.
来源: N Engl J Med. 2025年392卷21期2176-2177页

1251. TAVR for Asymptomatic Severe Aortic Stenosis.

作者: Francesco Natale.;Paolo Golino.;Giovanni Cimmino.
来源: N Engl J Med. 2025年392卷21期2176页

1252. Bedaquiline Activity against Leprosy.

作者: Abdoulaye Fomba.;Fadima C Haidara.;Mamoudou Kodio.;Catherine Arama.;Emmanuelle Cambau.;Aurélie Chauffour.;Nicolas Veziris.;Bettina E Broeckling.;Alaine K Warren.;Bertrand Cauchoix.;Alexandre Alcaïs.;Laurent Marsollier.;Henri Assé.;Mary Jackson.;Samba Ousmane Sow.;Ousmane Faye.;Vincent Jarlier.;Stewart T Cole.;Charlotte Avanzi.;Alexandra Aubry.;Roch C Johnson.
来源: N Engl J Med. 2025年392卷21期2174-2176页

1253. Debating Race and the Diagnosis of Anemia - How Medicine Moved Away from Race-Based Standards.

作者: Wingel Xue.;David S Jones.
来源: N Engl J Med. 2025年392卷21期2168-2173页

1254. Setting for Initial Education about Type 1 Diabetes.

作者: Ann Cheung.;Jose Bernardo Q Quintos.;Shivani Agarwal.
来源: N Engl J Med. 2025年392卷21期2164-2167页

1255. Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis.

作者: Tracey G Simon.
来源: N Engl J Med. 2025年392卷21期2160-2161页

1256. From Where It Stems.

作者: Ayelet Shapira-Daniels.;Karishma Pareek.;Matthew Cozzolino.;Jean-Antoine Ribeil.;Eric Awtry.
来源: N Engl J Med. 2025年392卷21期2151-2158页

1257. Lead Poisoning in a Child.

作者: Shalini H Shah.;Marissa Hauptman.
来源: N Engl J Med. 2025年392卷21期2150页

1258. The Fetal-to-Adult Hemoglobin Switch - Mechanism and Therapy.

作者: Stuart H Orkin.
来源: N Engl J Med. 2025年392卷21期2135-2149页

1259. A Trial of Trimethoprim-Sulfamethoxazole in Pregnancy to Improve Birth Outcomes.

作者: Bernard Chasekwa.;Fortunate Munhanzi.;Lenin Madhuyu.;Gabriel Mbewe.;Vincent Mabika.;Dzivaidzo Chidhanguro.;Tendai Kofi.;Jonthan Munengiwa.;Hilda Mapfumo.;Mercy Musapa.;Sipho Shumba.;Elizabeth Hungwe.;Mary Nhokwara.;Nester Bushe.;Rudo Kufa.;Phatisiwe Mazula.;Muchaneta Chikombingo.;Alice Tengende.;Admire Zanga.;Asaph Ziruma.;Tsitsi Bere.;Success Munyengwa.;Charity Mudimbu.;Zvikomborero Murwira.;Shepherd Mudzingwa.;Eddington Mpofu.;Batsirai Mutasa.;Virginia Sauramba.;Elisha Masakadze.;Thompson Runodamoto.;Courage Chiorera.;Alfred Mushininga.;Claire D Bourke.;Ruairi C Robertson.;Jeniffer Perussolo.;Nikos Donos.;Chandiwana Nyachowe.;Mary Muchekeza.;Jefrey Chikunya.;Melanie Smuk.;Kuda Mutasa.;Naume V Tavengwa.;Lisa L Langhaug.;Robert Ntozini.;Stephen P Munjanja.;Andrew J Prendergast.
来源: N Engl J Med. 2025年392卷21期2125-2134页
Maternal infections underlie several adverse birth outcomes. Whether trimethoprim-sulfamethoxazole prophylaxis during pregnancy will improve birth outcomes is unknown.

1260. Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.

作者: Eleftherios P Mamounas.;Hanna Bandos.;Julia R White.;Thomas B Julian.;Atif J Khan.;Simona F Shaitelman.;Mylin A Torres.;Frank A Vicini.;Patricia A Ganz.;Susan A McCloskey.;Peter C Lucas.;Nilendu Gupta.;X Allen Li.;Beryl McCormick.;Benjamin Smith.;Rahul D Tendulkar.;Vivek S Kavadi.;Koji Matsumoto.;Samantha Andrews Seaward.;William J Irvin.;Jolinta Y Lin.;Robert W Mutter.;Thierry M Muanza.;Jannifer Stromberg.;Reshma Jagsi.;Anna C Weiss.;Walter J Curran.;Norman Wolmark.
来源: N Engl J Med. 2025年392卷21期2113-2124页
The benefit of regional nodal irradiation in the treatment of breast cancer is well established for patients with pathologically positive axillary nodes, but whether it is also beneficial for patients whose nodes become pathologically tumor free (ypN0) after neoadjuvant chemotherapy remains unclear.
共有 87651 条符合本次的查询结果, 用时 6.2937923 秒